drugset / Trial / NCT01917825

A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy

NCT01917825 ↗

Phase 2 Completed 54 enrolled Medtronic Spinal and Biologics
NaSingle-groupOpen-labelTreatment

Summary

The primary objectives of this clinical trial are to investigate the pharmacokinetics and safety of MDT-15 pellets in escalating sequential doses administered to different cohorts. Preliminary efficacy data will also be collected for assessment.

Timeline

Start
2013-07
Primary completion
2015-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject MDT-15 Unknown 1 unknown —
Subject MDT-15 Unknown 3 unknown —
Subject MDT-15 Unknown 6 unknown —

Indications